United States · Series A startup

Who invested in Akrevia Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $30MSept 2018
Investors
2
See who backed them

The rounds

  1. Sept 2018
    Series A$30M

    Reported by FinSMEs

Everyone who backed them

Atlas VentureVC firm1round
F-Prime CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Akrevia Therapeutics

Who invested in Akrevia Therapeutics?

Akrevia Therapeutics's investors include Atlas Venture and F-Prime Capital.

How much has Akrevia Therapeutics raised?

Akrevia Therapeutics has raised $30M across 1 round since 2018.

When did Akrevia Therapeutics last raise?

Akrevia Therapeutics's most recent round was a Series A of $30M in Sept 2018.

What was Akrevia Therapeutics's biggest round?

Its most recent round, $30M in Sept 2018, is also its largest on record.

Who backed Akrevia Therapeutics first?

Akrevia Therapeutics's first round on record, in Sept 2018, was backed by Atlas Venture and F-Prime Capital.

What stage is Akrevia Therapeutics at?

Akrevia Therapeutics's latest named round is a Series A, in Sept 2018.

Where is Akrevia Therapeutics based?

Akrevia Therapeutics is based in the United States.

Companies like Akrevia Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.